Overview

Pharmacokinetics Study on Nevirapine Resistance in Tanzania

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Primary - pharmacokinetics of single dose nevirapine - the effect of single dose carbamazepine on the pk of single dose nevirapine - resistance against nevirapine before and after. - follow-up on HIV status newborns - relation between nevirapine levels in cord blood and plasma Secondary * safety of single dose nevirapine and nevirapine/carbamazepine Hypothesis: Single dose carbamazepine decreases development of resistance to nevirapine in HIV positive pregnant Tanzanian women by decreasing nevirapine half-life.
Phase:
Phase 2
Details
Lead Sponsor:
Radboud University
Treatments:
Carbamazepine
Nevirapine